The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: Challenges in implementation in the pediatric and neonatal intensive care units

Journal of Child Neurology

Volumn 30, Issue 2, 2015, Pages 259-266

  Cobo, Nicole H ^a   Sankar, Raman ^a,b   Murata, Kristina K ^a   Sewak, Sarika L ^a   Kezele, Michele A ^a   Matsumoto, Joyce H ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Children; Ketogenic diet; Pediatric; Refractory; Seizures; Status epilepticus

Indexed keywords

3 HYDROXYBUTYRIC ACID; CLOBAZAM; CLORAZEPATE; ETIRACETAM; FATTY ACID; FELBAMATE; FOLINIC ACID; GLUCOSE; HARKOSERIDE; IMMUNOGLOBULIN; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; TOPIRAMATE; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CONSTIPATION; CRITICALLY ILL PATIENT; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INFANT; INTENSIVE CARE UNIT; KETOACIDOSIS; KETOGENIC DIET; MALE; NEPHROLITHIASIS; NEWBORN INTENSIVE CARE; PATIENT SAFETY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPIKE WAVE; BLOOD; DIET THERAPY; ELECTROENCEPHALOGRAPHY; PROCEDURES; TREATMENT OUTCOME;

3-HYDROXYBUTYRIC ACID; ADOLESCENT; BLOOD GLUCOSE; CHILD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; KETOGENIC DIET; MALE; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84927702882     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813516192     Document Type: Article

References (25)

1. Chin RFM, Neville BGR, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11: 800-810.
2. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802-2818.
3. Barberio M, Reiter PD, Kaufman J, et al. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012;27:721-726.
4. Gulati Sh, Kalra V, Sridhar MR. Status epilepticus in Indian children in a tertiary care center. Indian J Pediatr. 2005;72:105-108.
5. Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001; 42:1461-1467.
6. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314-2328.
7. Wheless JW. Treatment of refractory convulsive status epilepticus in children: other therapies. Semin Pediatr Neurol. 2010;17: 190-194.
8. Freeman JM, Kossoff EH. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr. 2010;57:315-329.
9. Cervenka MC, Hartman AL, Venkatesan A, et al. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care. 2011;15:519-524.
10. Mikaeloff Y, Jambaqué I, Hertz-Pannier L, et al. Devastating Epileptic Encephalopathy in School-aged Children (DESC): a pseudo encephalitis. Epilepsy Res. 2006;69:67-79.
11. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia. 2010;51:2033-2037.
12. Nam SH, Bo LL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia. 2011;52: 181-184.
13. Villeneuve N, Pinton F, Bahi-Buisson N, et al. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol. 2009;51:276-281.
14. Wusthoff CJ, Kranick SM, Morley JF, et al. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 2010;51:1083-1085.
15. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia. 2009;50:304-317.
16. Weise K, Zaritsky A. Endocrine manifestations of critical illness in the child. Pediatr Clin North Am. 1987;34:119-130.
17. Srinivasan V, Spinella PC, Drott HR, et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Crit Care Med. 2004;5: 329-336.
18. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345: 1359-1367.
19. Smith H, Sinson H, Varelas P. Vasopressors and propofol infusion syndrome in severe head trauma. Neurocrit Care. 2009;10: 166-172.
20. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37:3024-3030.
21. Brody TM, Bain JA. Effect of barbiturates on oxidative phosphorylation. J Pharmacol Exp Ther. 1954;110:148-156.
22. Bhayana V, Alto LE, Dhalla NS. Effects of pentobarbital and pentothal on rat heart contractile force and oxidate phosphorylation activities. Gen Pharmacol. 1979;11:375-377.
23. Saks V, Favier R, Guzun R, et al. Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. J Physiol. 2006;577:769-777.
24. Forsey RG, Reid K, Brosnan JT. Competition between fatty acids and carbohydrates or ketone bodies as metabolic fuels for the isolated perfused heart. Can J Physiol Pharmacol. 1987;65: 401-406.
25. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64:477-502.